Research Topics
| Stephen M SetterSummaryAffiliation: College of Pharmacy Country: USA Publications
| Collaborators
|
Detail Information
Publications
Phosphodiesterase 5 inhibitors for erectile dysfunctionStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA 99217 6131, USA
Ann Pharmacother 39:1286-95. 2005..To review the pharmacologic and clinical trial data of the Food and Drug Administration-approved phosphodiesterase 5 (PDE5) inhibitors for the treatment of erectile dysfunction (ED)...- The Mini-Cog: a rapid dementia screening tool suitable for pharmacists' useStephen M Setter
Department of Pharmacotherapy, Colleg eof Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
Consult Pharm 22:855-61. 2007..To familiarize the consultant pharmacist with the use of the Mini-Cog as a rapid screening tool for the assessment of dementia and outline currently available evidence regarding the validity of this screening tool within the community... - Inhaled dry powder insulin for the treatment of diabetes mellitusStephen M Setter
Department of Pharmacotherapy, College o f Pharmacy, Washington State University, Spokane, WA 99217 6131, USA
Clin Ther 29:795-813. 2007..Inhaled dry powder insulin (IDPI) is the first inhaled insulin approved for the treatment of type 1 and type 2 diabetes mellitus (DM)... - Treatment of chorea associated with Huntington's disease: focus on tetrabenazineStephen M Setter
Washington State University Elder Sevices, Spokane, Washington 99217, USA
Consult Pharm 24:524-37. 2009..Review Huntington's disease (HD) and the role of tetrabenazine (TBZ) in treating chorea associated with this disease. Discuss the pharmacology, side-effect profile, drug interactions, precautions, and contraindications of TBZ... 
Effectiveness of a pharmacist-nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health careStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, USA
Am J Health Syst Pharm 66:2027-31. 2009..The effectiveness of a collaborative pharmacist-nurse intervention on resolving detected medication discrepancies as patients transitioned from hospital to home health care was evaluated...- Transitional care: exploring the home healthcare nurse's role in medication managementStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Elder Services, Spokane, Washington 99217 6131, USA
Home Healthc Nurse 30:19-26. 2012..Nurses must partner with pharmacists, physicians, and others involved with care transitions to decrease the likelihood of patients experiencing untoward health consequences associated with medications.-Eric A. ... - Assessing the impact of ease of administration and tolerability on treatment choices in Parkinson's diseaseStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Elder Services Visiting Nurses Association, 5125 North Market Street, Spokane, WA 99217 6131, USA
Neurol Clin 26:S45-63, vi. 2008..When prescribing antiparkinsonian therapies, the clinician should consider ease of administration, tolerability, and efficacy, along with other factors that are likely to contribute to optimal compliance by the patient... - Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapyStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane 99217 6131, USA
Clin Ther 25:2991-3026. 2003.... - Biochemical pathways for microvascular complications of diabetes mellitusStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA, USA
Ann Pharmacother 37:1858-66. 2003..To review the current biochemical theories on how diabetes contributes to microvascular disease... - A survey of the perceptions, knowledge, and use of A1C values by home care patients and nursesStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, USA
Diabetes Educ 29:144-52. 2003..The purpose of this study was to provide baseline information on the perceptions, use, and knowledge of hemoglobin A1C (A1C) values among home healthcare nurses and patients... - Screening for undiagnosed cognitive impairment in homebound older adultsStephen M Setter
Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
Consult Pharm 24:299-305. 2009..To screen for undetected cognitive impairment in homebound elders receiving home health care services... - Update in the pharmacologic treatment of diabetes: focus on insulin detemir, insulin glulisine, and inhaled dry powdered insulinJason L Iltz
Department of Pharmacotherapy, College of Pharmacy, Washington State University, PO Box 1495, Spokane, WA 99210 1495, USA
Diabetes Educ 33:215-6, 220, 223-4 passim. 2007..A detailed patient case designed to acquaint the reader with these newer insulin products and provide an understanding of clinical issues to consider when providing diabetes education to patients is included... - Colesevelam hydrochloride for the treatment of type 2 diabetes mellitusTravis E Sonnett
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Pullman, Washington 99164 6510, USA
Clin Ther 31:245-59. 2009.... - Pharmacological management of glycemic control in the geriatric patient with type 2 diabetes mellitusJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University Elderly Services, Spokane, Washington 99217 6131, USA
Consult Pharm 24:45-63. 2009.... - Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitusJason L Iltz
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, 99210 1495, USA
Clin Ther 28:652-65. 2006.... - Point-of-care screening to identify cognitive impairment in older adultsTravis E Sonnett
College of Pharmacy, Washington State University, P O Box 646510, Pullman, WA 99164 6510, USA
J Am Pharm Assoc (2003) 52:492-7. 2012.... - Review of linagliptin for the treatment of type 2 diabetes mellitusJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, 99210 1495, USA
Clin Ther 34:993-1005. 2012.... - Nurse identified hospital to home medication discrepancies: implications for improving transitional careCynthia F Corbett
College of Nursing, Washington State University, Spokane, WA, USA
Geriatr Nurs 31:188-96. 2010..Medication discrepancies were identified in virtually all classes of medications, including those with high safety risks. Evidence-based best practices to reduce transition-related medication discrepancies are presented... - Looking to the future: focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapiesJoshua J Neumiller
PharmD, Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, 5125 North Market Street, Spokane, WA 99217, USA
Diabetes Educ 34:183-200. 2008..This article, part 3 of a 3-part series, reviews the new class of medications known as DPP-4 inhibitors as well as discusses a future buccal insulin formulation, Oral-Lyn, on the horizon for the treatment of diabetes mellitus... 
Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetesJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington
Diabetes Metab Syndr Obes 3:215-26. 2010..Diligent postmarketing surveillance to elucidate the risk of pancreatitis and medullary thyroid carcinoma in a heterogeneous population are likely warranted...- Clinical review of treatment options for select nonmotor symptoms of Parkinson's diseaseLindy D Wood
Elder Services, Spokane, Washington, USA
Am J Geriatr Pharmacother 8:294-315. 2010..The nonmotor symptoms of PD have the potential to be more debilitating than the motor features of the disorder... - Pharmacologic management of the older patient with type 2 diabetes mellitusJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
Am J Geriatr Pharmacother 7:324-42. 2009.... - OASIS and beyond: improving outcomes for home health patientsCynthia F Corbett
Intercollegiate College of Nursing, Washington State University, 2715 West Fort George Wright Drive, Spokane, WA 99224, USA
Diabetes Educ 29:83-9. 2003 - Rate of obesity in U.S. ambulatory patients with diabetes mellitus: a national assessment of office-based physician visitsJoshua J Neumiller
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, United States
Prim Care Diabetes 3:197-9. 2009..S. National Ambulatory Medical Care Survey (NAMCS). Our findings indicate a significant proportion of U.S. ambulatory patients with DM present with obesity and greater clinical acuity than patients with DM alone... - Pregabalin for the treatment of painful neuropathyTravis E Sonnett
Washington State University, College of Pharmacy, Family Home Care Corporation, 9922 E Montgomery Avenue, Suite 3, Spokane, WA 99206, USA
Expert Rev Neurother 6:1629-35. 2006..This article will review each of these studies, as well as provide a clinical review for the use of pregabalin in the treatment of neuropathic pain... - Exploring the concept of medication discrepancy within the context of patient safety to improve population healthCatherine R Murphy
Pullman Regional Hospital, Pullman, Washington, USA
ANS Adv Nurs Sci 32:338-50. 2009..Conceptual clarity about the various aspects of medication discrepancy in the context of patient safety has the potential to enhance quality improvement efforts and patient outcomes to improve population health... - Meloxicam: a reappraisal of pharmacokinetics, efficacy and safetyBrian J Gates
College of Pharmacy, Department of Pharmaceutical Sciences, Washington State University, Pullman, Washington 99164-6534, USA
Expert Opin Pharmacother 6:2117-40. 2005..The pharmacokinetics of meloxicam enables once daily application, which increases compliance compared with some shorter acting NSAIDs; however, long-term clinical data clearly demonstrating safety and efficacy advantages are lacking... - Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organismsMark W Garrison
Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington 99210 1495, USA
Clin Ther 27:12-22. 2005..Tigecycline is an investigational glycylcycline antibiotic that shows promising activity against these resistant gram-positive organisms... - Update in the pharmacologic treatment of diabetes mellitus: focus on pramlintide and exenatidePeggy Soule Odegard
Geriatrics Program, School of Pharmacy, University of Washington, Box 357630, 1959 NE Pacific Street, Seattle, WA 98195, USA
Diabetes Educ 32:693-712. 2006..Cases will be used to assist with understanding the type of patient who will benefit from each of these new therapies... - The use of anticholinergic medications in homebound elderly patients with dementiaWen-Yi Chan
Centre for Socioeconomic Research, Welsh School of Pharmacy, Cardiff University, Wales, UK
Consult Pharm 21:391-9. 2006..CONCLUSION: Drugs with anticholinergic activity are used frequently in an older homebound population, irrespective of a dementia diagnosis... - Diabetic neuropathy: an intensive reviewJeremiah John Duby
University of Arizona, Tucson, AZ, USA
Am J Health Syst Pharm 61:160-73; quiz 175-6. 2004..Glycemic control remains the foundation of prevention and the prerequisite of adequate treatment. CONCLUSION: Diabetic neuropathy is a many-faceted complication of diabetes that can be managed symptomatically with an array of drugs...